IRIS
MENZO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.241
EU - Europa 3.011
AS - Asia 2.460
SA - Sud America 479
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 143
OC - Oceania 3
Totale 12.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.118
SG - Singapore 829
IT - Italia 529
RU - Federazione Russa 514
VN - Vietnam 500
UA - Ucraina 469
BR - Brasile 372
CN - Cina 365
DE - Germania 290
IE - Irlanda 279
HK - Hong Kong 240
SE - Svezia 201
FR - Francia 178
DK - Danimarca 171
FI - Finlandia 132
TR - Turchia 126
GB - Regno Unito 119
KR - Corea 96
BD - Bangladesh 82
CI - Costa d'Avorio 66
CA - Canada 61
IN - India 56
AR - Argentina 40
MX - Messico 39
NL - Olanda 31
IQ - Iraq 27
ZA - Sudafrica 27
MA - Marocco 22
PL - Polonia 22
AT - Austria 21
ID - Indonesia 19
CO - Colombia 16
VE - Venezuela 15
BE - Belgio 14
PK - Pakistan 14
ES - Italia 13
JP - Giappone 13
UZ - Uzbekistan 13
PH - Filippine 12
SA - Arabia Saudita 11
EC - Ecuador 10
CL - Cile 8
CR - Costa Rica 7
DZ - Algeria 7
MY - Malesia 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
EU - Europa 5
JO - Giordania 5
KE - Kenya 5
LT - Lituania 5
NP - Nepal 5
PA - Panama 5
RO - Romania 5
TN - Tunisia 5
IL - Israele 4
PY - Paraguay 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EG - Egitto 3
OM - Oman 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MK - Macedonia 2
MN - Mongolia 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
Totale 12.338
Salva come PNG Salva come JPEG
Città #
Ashburn 816
Singapore 487
Jacksonville 475
Chandler 432
Fairfield 371
San Jose 319
Des Moines 303
Dublin 279
Council Bluffs 257
Boardman 246
Hong Kong 226
Dallas 218
Wilmington 189
Woodbridge 166
Houston 159
New York 151
Ho Chi Minh City 145
Seattle 143
The Dalles 115
Ann Arbor 106
Lawrence 106
Princeton 106
San Mateo 106
Hanoi 105
Los Angeles 101
Cambridge 98
Lauterbourg 95
Moscow 76
Beijing 69
Abidjan 66
Hefei 62
Redmond 60
Ancona 54
San Diego 51
Buffalo 47
Milan 47
Civitanova Marche 39
Chicago 38
Helsinki 36
London 36
Munich 34
Da Nang 32
São Paulo 30
Orem 28
Centro 27
Santa Clara 23
Montreal 22
Phoenix 22
Rome 21
Turin 19
Warsaw 19
Shanghai 17
Chennai 16
Mexico City 16
Miano 16
Haiphong 15
Johannesburg 15
Nuremberg 15
Brussels 14
Marche 14
Wuhan 14
Rio de Janeiro 13
Guangzhou 12
Manchester 12
Tashkent 12
Toronto 12
Baghdad 11
Frankfurt am Main 11
Washington 11
Amsterdam 10
Appignano 10
Norwalk 10
Ankara 9
Hanover 9
Ninh Bình 9
Pune 9
Boston 8
Brooklyn 8
Denver 8
Iesi 8
Stockholm 8
Tokyo 8
Atlanta 7
Can Tho 7
Falls Church 7
Goiânia 7
Hải Dương 7
Porto Alegre 7
Quận Một 7
San Francisco 7
San José 7
Tampa 7
Turku 7
Vienna 7
Bari 6
Belo Horizonte 6
Biên Hòa 6
Cape Town 6
Dhaka 6
Fayetteville 6
Totale 7.758
Salva come PNG Salva come JPEG
Nome #
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 230
A clone of linezolid-resistant Staphylococcus epidermidis bearing the G2576T mutation is endemic in an Italian hospital 213
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing 200
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 197
SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor 184
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 175
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. 169
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 165
High prevalence of carbapenem-resistant Klebsiella pneumoniae ST307 recovered from faecal samples in an Italian hospital 156
Increase and diversity of carbapenemase-producing Escherichia coli isolates, Italy 153
Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. 153
Competitive polymerase chain reaction and analysis of viral activity at the molecular level. 149
Visceral fat inflammation and fat embolism are associated with lung's lipidic hyaline membranes in subjects with COVID-19 149
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. 148
Hepatitis E in a region of Italy: An emerging autochthonous infection? 145
Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. 144
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. 142
Molecular epidemiology and pathogenetic potential of underdiagnosed human papillomavirus types. 140
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 139
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 139
Tocilizumab in COVID-19 interstitial pneumonia 138
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. 137
Autochthonous dengue outbreak in Marche Region, Central Italy, August to October 2024 136
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 136
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 134
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. 132
Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. 128
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types 127
Analisi della regione tet(O)-mef(A) in un elemento orf3-negativo di Streptococcus pyogenes. 126
First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid 124
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 123
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 119
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. 118
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 118
Vaginal micropapillary lesions are not related to human papillomavirus infection: in situ hybridization and polymerase chain reaction detection techniques 118
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. 116
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. 116
Quantitative PCR and RT-PCR in virology. 115
Quantitative molecular methods in virology. 113
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 113
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC 113
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. 112
Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation 112
A large epidemic of hepatitis B in Serbia: an integrated model for outbreak investigations in healthcare settings 111
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 111
Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. 109
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. 109
Eritromicino-resistenza da efflusso in ceppi tetraciclino-sensibili (Tcs) e tetraciclino-resistenti (Tcr) di Streptococcus pyogenes. 106
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. 106
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan 105
42. Adenoviridae 105
A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. 105
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. 104
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. 102
The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining 102
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment. 102
A statistical model based on serological parameters for predicting occult HBV infection: implications for organ/ blood donations 101
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 100
Clearance of HIV-1 viraemia after seroconversion. 100
Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. 99
Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. 97
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 97
HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system 97
Weak cross-lineage neutralization by anti sars-cov-2 spike antibodies after natural infection or vaccination is rescued by repeated immunological stimulation 97
Serological response after anti-SARS-CoV-2 BNT162b2 vaccine in IBD patients on biological therapy: a monocentric case-control study 96
Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment 96
Human papillomavirus infections: new perspectives for prevention and treatment. 94
Comparison of HIV-1 recombinant phenotypic assays and virtual phenotype in the definition of coreceptor usage 93
Immune response, rather than sensitivity to entecavir, may determine the rate of viral decay upon treatment initiation in patients with chronic HBV infection 92
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 (HIV-1) infection 91
Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus. 90
Long-term follow-up of acute hepatitis B: New insights in its natural history and implications for antiviral treatment 90
Italian Patent with european extension: New molecular vector for the geno-phenotypic characteristics of V3 sequences of the HIV gp120. 89
Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. 89
Simple and reliable method to quantify the hepatitis B viral load and replicative capacity in liver tissue and blood leukocytes 88
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 87
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands. 87
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. 86
Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy. 85
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. 85
Insulin-like growth factor 1 (IGF-1) expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab-irinotecan. 85
Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function. 83
Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro. 83
The introduction of the fusion inhibitors in the HAART-regimens. 83
European Patent n° EPO 99830776.3: Method to evaluate the HIV drug sensitivity 83
Lack of Chlamydia infection of the central nervous system in multiple sclerosis. 83
Quantitation of hepatitis C virus genome molecules in plasma samples. 83
Viral dynamics and mutations in the pol gene during primary HIV-1 infection. 82
Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic. 82
Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants 82
Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO. 81
Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. 81
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022-2023 80
Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues. 80
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds 79
Intra-host evolution of human immunodeficiency virus type 1 and viral fitness. 79
Hemagglutinin 222 variants in pandemic (H1N1) 2009 virus. 79
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy. 78
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). 78
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy. 77
Totale 11.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.887
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022576 0 0 13 23 10 52 51 58 67 56 67 179
2022/20231.513 133 112 121 109 115 392 8 70 325 6 96 26
2023/2024789 131 16 49 117 165 144 7 40 8 12 12 88
2024/20251.687 203 147 82 9 55 48 173 63 470 127 139 171
2025/20264.324 263 265 203 382 453 307 841 450 370 404 163 223
2026/2027467 162 178 127 0 0 0 0 0 0 0 0 0
Totale 12.483